Math Biology has been officially selected to participate in #ATLASNEXT 2025, taking place in New York from October 13–16, 2025. This prestigious initiative, organized by Associazione ATLAS, is designed to help Italian startups expand into the U.S. innovation ecosystem by connecting them with accelerators, investors, institutional stakeholders, and industry leaders.

The highlight of the event for Math Biology will be the official pitch at Newlab in Brooklyn, where the team will present its groundbreaking technology, DMA®, to an international audience. DMA® is an AI-powered, non-invasive solution that reveals hidden metabolic imbalances, enabling doctors and patients to understand the root causes of pain without invasive procedures. By analyzing metabolic patterns and electrical signals, DMA® supports early detection, personalized care, and better health outcomes.

Participation in ATLAS NEXT 2025 provides Math Biology with a unique opportunity to gain visibility in the global health tech community, establish strategic partnerships, and explore the U.S. market. The startup will join other selected Italian innovators in a series of meetings, workshops, and networking events designed to foster collaboration and growth.

This milestone underscores Math Biology’s commitment to transforming healthcare through AI and non-invasive diagnostics, advancing the frontier of personalized medicine.